A NEW METHOD TO EVALUATE THE CLINICAL EFFICACY OF PIRFENIDONE FOR PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS BY USING PERSONAL FORCED VITAL CAPACITY CHANGE

被引：0
|
作者：
Yamauchi, Hiroyoshi [1 ]
Bando, Masashi [1 ,2 ]
Ogura, Takashi [2 ,3 ]
Suda, Takafumi [2 ,4 ]
Taniguchi, Hiroyuki [2 ,5 ]
Mukae, Hiroshi [2 ,6 ]
Kishi, Kazuma [2 ,7 ]
Sugiyama, Yukihiko [1 ,2 ]
机构：
[1] Jichi Med Univ, Dept Med, Div Pulm Med, Shimotsuke, Tochigi, Japan
[2] Minist Hlth Labour & Welf, Tokyo, Japan
[3] Kanagawa Cardiovasc & Resp Ctr, Dept Resp Med, Yokohama, Kanagawa, Japan
[4] Hamamatsu Univ Sch Med, Dept Resp Med, Shizuoka, Japan
[5] Tosei Gen Hosp, Dept Resp Med & Allergy, Seto, Aichi, Japan
[6] Univ Occupat & Environm Hlth, Dept Resp Med, Fukuoka, Japan
[7] Toranomon Gen Hosp, Dept Resp Med, Tokyo, Japan
来源：
RESPIROLOGY | 2014年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P-I-016
引用
收藏
页码：151 / 151
页数：1
相关论文
共 50 条
  • [41] EFFECT OF CONTINUED TREATMENT WITH PIRFENIDONE FOLLOWING A ≥ 10% RELATIVE DECLINE IN PERCENT PREDICTED FORCED VITAL CAPACITY (%FVC) IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF)
    Wells, A. U.
    Albera, C.
    Costabel, U.
    Glaspole, I.
    Glassberg, M. K.
    Lancaster, L.
    Lederer, D. J.
    Pereira, C. A.
    Swigris, J. J.
    Day, B-M
    Chou, W.
    Nathan, S. D.
    THORAX, 2016, 71 : A178 - A178
  • [42] Randomized Phase 2 Study of Nintedanib with or Without Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis Who Experienced a Clinically Meaningful Decline in Forced Vital Capacity During Prior Pirfenidone Administration
    Ikeda, S.
    Sekine, A.
    Baba, T.
    Katano, T.
    Tabata, E.
    Shintani, R.
    Yamakawa, H.
    Oda, T.
    Okuda, R.
    Kitamura, H.
    Iwasawa, T.
    Takemura, T.
    Ogura, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [43] Efficacy of Pirfenidone in Patients with Advanced-stage Idiopathic Pulmonary Fibrosis
    Sakamoto, Susumu
    Itoh, Takafumi
    Muramatsu, Yoko
    Satoh, Keita
    Ishida, Fumiaki
    Sugino, Keishi
    Isobe, Kazutoshi
    Homma, Sakae
    INTERNAL MEDICINE, 2013, 52 (22) : 2495 - 2501
  • [44] Patients With Idiopathic Pulmonary Fibrosis And Forced Vital Capacity <50% Predicted: Is There A Role For Antifibrotic Therapy?
    Galli, J.
    Pandya, A.
    Dorey-Stein, Z.
    Vega-Olivo, M.
    Criner, G. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [45] Relationship Between MRNA-microRNA Interactions and Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis
    Noth, I.
    Roy, J.
    Schmid, R.
    Vinisko, R.
    Strobel, B.
    Neely, M. L.
    Hesslinger, C.
    Belperio, J. A.
    Flaherty, K. R.
    Salisbury, M. L.
    Oldham, J.
    Palmer, S. M.
    Todd, J. L.
    Leonard, T. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [46] Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis Test Properties and Minimal Clinically Important Difference
    du Bois, Roland M.
    Weycker, Derek
    Albera, Carlo
    Bradford, Williamson Z.
    Costabel, Ulrich
    Kartashov, Alex
    King, Talmadge E., Jr.
    Lancaster, Lisa
    Noble, Paul W.
    Sahn, Steven A.
    Thomeer, Michiel
    Valeyre, Dominique
    Wells, Athol U.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 184 (12) : 1382 - 1389
  • [47] Impact of body weight change on clinical outcomes in patients with idiopathic pulmonary fibrosis receiving pirfenidone
    Kim, Tae Hun
    Shin, Yune-Young
    Kim, Hyung-Jun
    Song, Myung Jin
    Kim, Yeon Wook
    Lim, Sung Yoon
    Lee, Yeon Joo
    Park, Jong Sun
    Cho, Young-Jae
    Lee, Jae Ho
    Lee, Choon-Taek
    Kwon, Byoung Soo
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [48] Impact of body weight change on clinical outcomes in patients with idiopathic pulmonary fibrosis receiving pirfenidone
    Tae Hun Kim
    Yune-Young Shin
    Hyung-Jun Kim
    Myung Jin Song
    Yeon Wook Kim
    Sung Yoon Lim
    Yeon Joo Lee
    Jong Sun Park
    Young-Jae Cho
    Jae Ho Lee
    Choon-Taek Lee
    Byoung Soo Kwon
    Scientific Reports, 12
  • [49] 6 Minute Walk Distance (6MWD) and Forced Vital Capacity (FVC) in Patients with Idiopathic Pulmonary Fibrosis (IPF): Similar Pattern of Pirfenidone Response
    Valeyre, D.
    Albera, C.
    du Bois, R. M.
    Bradford, W. Z.
    Costabel, U.
    King, T. E., Jr.
    Noble, P. W.
    Szwarcberg, J.
    Sahn, S. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [50] The Ratio Of Forced Expiratory Volume In One Second To The Change In Forced Vital Capacity From Predicted Baseline Is An Earlier marker Of Disease Progression In Idiopathic Pulmonary Fibrosis Than Change In Forced Vital Capacity Alone
    Perez, R. L.
    Vicary, G. W.
    Barber, C. W.
    Furmanek, S.
    Wiemken, T.
    Mattingly, B.
    Persaud, A.
    Guinn, B.
    Roman, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
12345